LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

266.53 -1.99

Rezumat

Modificarea prețului

24h

Curent

Minim

265.11

Maxim

270.9

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

39.864

77.671

EPS

1.96

Randament dividend

0.3

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+28.26% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.30%

2.35%

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-409M

19B

Deschiderea anterioară

268.52

Închiderea anterioară

266.53

Sentimentul știrilor

By Acuity

50%

50%

169 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 dec. 2025, 23:46 UTC

Market Talk

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 dec. 2025, 23:38 UTC

Market Talk

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 dec. 2025, 22:32 UTC

Achiziții, Fuziuni, Preluări

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 dec. 2025, 22:25 UTC

Achiziții, Fuziuni, Preluări

Westgold's Indicative Timetable Points to Early February Completion

16 dec. 2025, 22:24 UTC

Achiziții, Fuziuni, Preluări

Westgold: Divestment Aligns With Broader Corporate Strategy

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold: Deferred Payment Based on Performance Hurdles

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Divesting Noncore Operating Asset for A$64.6M

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 dec. 2025, 21:53 UTC

Câștiguri

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 dec. 2025, 21:17 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Sales $327.5M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q EPS 55c >WOR

16 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 dec. 2025, 21:05 UTC

Achiziții, Fuziuni, Preluări

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 dec. 2025, 20:44 UTC

Market Talk

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 dec. 2025, 20:04 UTC

Market Talk

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 dec. 2025, 20:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

28.26% sus

Prognoză pe 12 luni

Medie 348.7 USD  28.26%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

169 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat